The company
Alpha Tau Medical Ltd. -
DRTS · Nasdaq
DRTS stood above a rising 150-day average in 52 of the last 52 weekly readings, every one of them. It is 11.1% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 52 in a row
- Industry in uptrend
- 27% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $3.1M
- Officials’ trades on record
- 0
- Institutions holding
- 71 (+20)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 52 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Raphi LevyChief Financial Officer | sold | 2,871at $15.00 | 21 Aug 2026filed 25 Aug 2026 |
| Raphi LevyChief Financial Officer | sold | 17,730at $14.00 | 11 Aug 2026filed 12 Aug 2026 |
| Raphi LevyChief Financial Officer | sold | 2,270at $14.00 | 6 Jul 2026filed 7 Jul 2026 |
| Raphi LevyChief Financial Officer | sold | 17,873at $13.00 | 2 Jul 2026filed 6 Jul 2026 |
| Raphi LevyChief Financial Officer | sold | 2,127at $13.02 | 1 Jul 2026filed 2 Jul 2026 |
| Raphi LevyChief Financial Officer | sold | 20,000at $12.00 | 30 Jun 2026filed 1 Jul 2026 |
| Raphi LevyChief Financial Officer | sold | 4,222at $11.00 | 25 Jun 2026filed 26 Jun 2026 |
| Raphi LevyChief Financial Officer | sold | 15,778at $11.00 | 25 Jun 2026filed 26 Jun 2026 |
| Raphi LevyChief Financial Officer | sold | 15,000at $9.47 | 23 Jun 2026filed 25 Jun 2026 |
| Raphi LevyChief Financial Officer | sold | 2,500at $10.00 | 23 Jun 2026filed 25 Jun 2026 |
| Raphi LevyChief Financial Officer | sold | 17,500at $10.90 | 3 Jun 2026filed 4 Jun 2026 |
| Raphi LevyChief Financial Officer | sold | 15,000at $10.76 | 3 Jun 2026filed 4 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Gem Investment Advisors, LLCadded · filed 11 Aug 2026 | 1,434,476$18.0M | +1,320,740+1161.2% |
| HighTower Advisors, LLCunchanged · filed 5 Aug 2026 | 874,994$11.0M | 00.0% |
| BOOTHBAY FUND MANAGEMENT, LLCnew · filed 14 Aug 2026 | 773,481$9.7M | +773,481 |
| Aquamarine Financial (Cayman) Ltdunchanged · filed 12 Aug 2026 | 721,501$9.1M | 00.0% |
| Pier Capital, LLCnew · filed 5 Aug 2026 | 691,939$8.7M | +691,939 |
| UBS Group AGadded · filed 13 Aug 2026 | 642,263$8.1M | +355,575+124.0% |
| Apella Capital, LLCunchanged · filed 8 Jul 2026 | 382,284$4.9M | 00.0% |
| ARK Investment Management LLCreduced · filed 14 Aug 2026 | 277,086$3.5M | -15,048−5.2% |
| POLEN CAPITAL MANAGEMENT LLCnew · filed 4 Aug 2026 | 220,751$2.8M | +220,751 |
| Focus Partners Wealthadded · filed 12 Aug 2026 | 184,726$2.3M | +152,461+472.5% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.